Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $364.1700 (1.36%) ($355.0100 - $364.8000) on Wed. Feb. 1, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 48 | Latest Price | $364.1700(1.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.9% a day on average for past five trading days. | Weekly Trend | REGN declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) QQQ(42%) IVW(41%) | Factors Impacting REGN price | REGN will decline at least -1.43% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
1 - 5 Day Possible Target | $349.12(-4.13%) | 5 Day Moving Average | $351.04(3.74%) | 10 Day Moving Average | $353.16(3.12%) | 20 Day Moving Average | $359.84(1.2%) | To recent high | -18.1% | To recent low | 8.4% | Market Cap | $38.612b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |